Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Pinana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garcia-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendano-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R, Solano C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Front Oncol. 2024 Jun 19;14:1389345. doi: 10.3389/fonc.2024.1389345. eCollection 2024. PubMed PMID: 39015498; PubMed Central PMCID: PMC11250586.
AÑO: 2024; IF: 3.3
39015498
Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, Fernandez-Mercado M, Larrayoz MJ, Gutierrez NC, Fernandez-Guijarro M, Gonzalez-Calle V, Rodriguez-Otero P, Oriol A, Rosinol L, Alegre A, Escalante F, De La Rubia J, Teruel AI, De Arriba F, Hernandez MT, Lopez-Jimenez J, Ocio EM, Puig N, Paiva B, Lahuerta JJ, Blade J, San Miguel JF, Mateos MV, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R; GEM/PETHEMA (Grupo Espanol de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatias Malignas) cooperative study group. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood Cancer J. 2024 Apr 29;14(1):74. doi: 10.1038/s41408-024-01053-3. PubMed PMID: 38684670; PubMed Central PMCID: PMC11059156.
AÑO: 2024; IF: 11.6
38684670
Plasencia Martinez JM, Garcia Tuells I, Bravo Perez C, Blanco Barrio A. Target sign in COVID-19, radiological interpretation and diagnostic contribution of digital thoracic tomosynthesis. Radiologia (Engl Ed). 2024 Apr;66 Suppl 1:S32-S39. doi: 10.1016/j.rxeng.2023.07.005. Epub 2024 Feb 15. PubMed PMID: 38642959.
AÑO: 2024
38642959
Vicente AI, Luna I, Ruiz JC, Remigia MJ, Jerez A, Lluch R, Llopis I, Marco MJ, Benet C, Alonso C, Linares MD, Serrano L, Orero MT, Ortuno FJ, Senent ML. WHO/ICC Classification for Myelodysplastic Neoplasms/Syndromes Performs Better for Subtype Cytomorphological Diagnosis? Diagnostics (Basel). 2024 Jul 29;14(15):1631. doi: 10.3390/diagnostics14151631. PubMed PMID: 39125507; PubMed Central PMCID: PMC11312140.
AÑO: 2024; IF: 3.3
39125507
Mosquera-Orgueira A, Arellano-Rodrigo E, Garrote M, Martin I, Perez-Encinas M, Gomez-Casares MT, Hernandez-Sanchez A, Ferrer-Marin F, Mora E, Velez P, Ayala R, Angona A, Heras NL, Magro E, Perez-Miguez C, Crucitti D, Mata-Vazquez MI, Fox ML, Gonzalez de Villambrosia S, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin MA, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Nangalia J, Hernandez-Rivas JM, Bellosillo B, Alvarez-Larran A, Hernandez-Boluda JC; Spanish MPN Group (GEMFIN). Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis. Hemasphere. 2024 Mar 20;8(3):e60. doi: 10.1002/hem3.60. eCollection 2024 Mar. No abstract available. PubMed PMID: 38510992; PubMed Central PMCID: PMC10951878.
AÑO: 2024; IF: 14.6
38510992
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL